Royal DSM in Talks to Acquire Aland Neutraceutical of China

Royal DSM, a Dutch science company with interests in health, nutrition and materials, has entered an exclusive discussion to acquire Aland Nutraceutical of China. Aland is known mainly for its vitamin C business, although it also produces other nutritional supplements. Because Aland’s revenues were only $90 million last year, DSM characterized the potential takeover as a “relatively small acquisition.” More details.... Share this with colleagues: // //  
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.